Position in JNJ
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$389,843
+$19,517 QoQ
Shares Held
1,535
+1.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.37%
of 13F equity value
Holder Rank
#3,948
of 4,676 holders
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026IAM Advisory, LLC holds $17,989,599 across 8 Drug Manufacturers - General names. JNJ ranks #7 (2.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,638 | $5,562,956 | |
| 2 | MRK |
Merck & Co., Inc.
|
23,515 | $3,021,677 | |
| 3 | AMGN |
Amgen Inc
|
7,484 | $2,710,106 | |
| 4 | NVS |
Novartis AG
|
16,635 | $2,607,037 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
33,075 | $1,905,781 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
11,409 | $1,441,413 | |
| 7 | JNJ |
Johnson & Johnson
This page
|
1,535 | $389,843 | |
| 8 | ABBV |
AbbVie Inc.
|
1,394 | $350,786 |
All Filings in JNJ
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $389,843 | 1,535 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $370,326 | 1,515 | Shares | Sole | 2026-04-10 | |
| 2025-12-31 | $320,979 | 1,551 | Shares | Sole | 2026-01-07 | |
| 2025-09-30 | $283,136 | 1,527 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $231,569 | 1,516 | Shares | Sole | 2025-07-08 | |
| 2025-03-31 | $241,297 | 1,455 | Shares | Sole | 2025-04-11 | |
| 2024-12-31 | $241,660 | 1,671 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $289,115 | 1,784 | Shares | Sole | 2024-10-07 | |
| 2024-06-30 | $270,688 | 1,852 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $290,436 | 1,836 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $290,752 | 1,855 | Shares | Sole | 2024-01-12 | |
| 2023-09-30 | $283,465 | 1,820 | Shares | Sole | 2023-10-10 | |
| 2023-06-30 | $271,452 | 1,640 | Shares | Sole | 2023-07-13 | |
| 2023-03-31 | $223,200 | 1,440 | Shares | Sole | 2023-04-10 | |
| 2022-12-31 | $245,543 | 1,390 | Shares | Sole | 2023-01-18 | |
| 2022-09-30 | $695,096 | 4,255 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $642,763 | 3,621 | Shares | Sole | 2022-07-12 | |
| 2022-03-31 | $651,674 | 3,677 | Shares | Sole | 2022-04-14 | |
| 2021-12-31 | $540,923 | 3,162 | Shares | Sole | 2022-01-19 | |
| 2021-09-30 | $510,017 | 3,158 | Shares | Sole | 2021-10-14 | |
| 2021-03-31 | $517,538 | 3,149 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $494,960 | 3,145 | Shares | Sole | 2021-02-08 | |
| No filing history on record for this holder in this stock. | ||||||